Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
FDA Drug Recalls
6,161 recalls · Class II, newest first
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
potassium phosphate
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
potassium phosphate 15 mmole added to 0.9% sodium Chloride 250 mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
norepinephrine
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
NORepinephrine 4 mg/250 mL added to 0.9% sodium chloride 16 mcg/mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN 20 units added to Lactated Ringer's 1000 mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
neostigmine 5 mg/5mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
heparin 7500 units added to 0.9% sodium chloride 1000mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
heparin 5000 units/500mL added to 0.9% sodium chloride
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
heparin 4000 units/1000mL added to 0.9% sodium chloride
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.